By:
On:
In: Good company, Stock analysis
Tagged:
With: 0 Comments

Company name Catamaran Corp (USA)
Stock ticker CTRX
Live stock price [stckqut]CTRX[/stckqut]
P/E compared to competitors Fair

MANAGEMENT EXECUTION

Employee productivity Good
Sales growth Good
EPS growth Good
P/E growth Poor
EBIT growth Good

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $65.83
Target stock price (averages with growth) $70.03
Target stock price (averages with no growth) $31.67
Target stock price (manual assumptions) $59.89

The following company description is from Google Finance: http://www.google.com/finance?q=ctrx

Catamaran Corporation (Catamaran), formerly SXC Health Solutions Corp., is a provider of pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefit management industry. The Company’s product offerings and solutions combine a range of applications and PBM services designed to assist its customers in reducing the cost and managing the complexity of their prescription drug programs. The Company’s customers include organizations in the pharmaceutical supply chain, such as pharmacy benefit managers, managed care organizations, self-insured employer groups, unions, third party health care plan administrators, and state and federal government entities. In January 2012, the Company completed its acquisition of HealthTran LLC (HealthTran). On July 2, 2012, the Company acquired Catalyst Health Solutions, Inc. On October 1, 2013, the Company acquired RESTAT, LLC.

 

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in Catamaran Corp (USA).

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Catamaran Corp (USA) calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $42.7
  • Growth: 0.18
  • Current EPS (TTM): $1.36
  • P/E: 31
  • Future EPS Calc: $3.11
  • Future Stock Price Calc: $96.45
  • Target stock price: $59.88

I hope that this makes you a better investor. [/s2If]

By:
On:
In: Poor company, Stock analysis
Tagged:
With: 0 Comments

Company name Affymetrix, Inc.
Stock ticker AFFX
Live stock price [stckqut]AFFX[/stckqut]
Confident Investor Rating Poor

The following company description is from Google Finance: http://www.google.com/finance?q=affx

Affymetrix, Inc. (Affymetrix) is engaged in the development, manufacture, sale and service of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets. Affymetrix has developed its GeneChip system and related microarray technology as a platform for acquiring, analyzing and managing genetic information. The Company offers a line of products for two principal applications: genotyping and gene expression. Related microarray technology also offered by Affymetrix includes licenses for fabricating, scanning, collecting and analyzing results from complementary technologies. The Company also sells some of its products through life science supply specialists acting as authorized distributors in Latin America, India, the Middle East and Asia Pacific regions, including China. In October 2013, StoneCalibre announced that the completion of the acquisition of Anatrace, a part of Affymetrix, Inc.
Confident Investor comments: At this price and at this time, I do not think that a Confident Investor can confidently invest in Affymetrix, Inc. It is not possible to confidently invest in a company that is not currently profitable.
If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.

By:
On:
In: Fair company, Stock analysis
Tagged:
With: 0 Comments

Company name Delta Air Lines, Inc.
Stock ticker DAL
Live stock price [stckqut]DAL[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Good
Sales growth Poor
EPS growth Poor
P/E growth Poor
EBIT growth Good

ANALYSIS

Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $50.86
Target stock price (averages with growth) $46.19
Target stock price (averages with no growth) $19.22
Target stock price (manual assumptions) $45.41

The following company description is from Google Finance: http://www.google.com/finance?q=dal

Delta Air Lines, Inc. (Delta) provides scheduled air transportation for passengers and cargo throughout the United States and around the world. The Company’s route network gives it a presence in every domestic and international market. Delta’s route network is centered around the hub system it operate at airports in Amsterdam, Atlanta, Cincinnati, Detroit, Memphis, Minneapolis-St. Paul, New York-JFK, Paris-Charles de Gaulle, Salt Lake City and Tokyo-Narita. Each of these hub operations includes flights that gather and distribute traffic from markets in the geographic region surrounding the hub to domestic and international cities and to other hubs. The Company’s network is supported by a fleet of aircraft that is varied in terms of size and capabilities. In June 2013, Delta Air Lines Inc acquired a 49% stake in Virgin Atlantic Airways Ltd.

 

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in Delta Air Lines, Inc. as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Delta Air Lines, Inc. calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $32.91
  • Growth: 0.14
  • Current EPS (TTM): $12.66
  • P/E: 3
  • Future EPS Calc: $24.37
  • Future Stock Price Calc: $73.12
  • Target stock price: $45.4

I hope that this makes you a better investor. [/s2If]

By:
On:
In: Poor company, Stock analysis
Tagged:
With: 0 Comments

Company name Coherent, Inc.
Stock ticker COHR
Live stock price [stckqut]COHR[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Poor
Sales growth Poor
EPS growth Poor
P/E growth Fair
EBIT growth Good

ANALYSIS

Confident Investor Rating Poor
Target stock price (TWCA growth scenario) $41.85
Target stock price (averages with growth) $41.6
Target stock price (averages with no growth) $25.75
Target stock price (manual assumptions) $50.78

The following company description is from Google Finance: http://www.google.com/finance?q=cohr

Coherent, Inc. (Coherent) is a suppliers of photonics-based solutions in a range of commercial and scientific research applications. The Company designs, manufactures, service and markets lasers and related accessories for a group of customers. The Company is organized into two operating segments: Commercial Lasers and Components (CLC) and Specialty Lasers and Systems (SLS). CLC’s markets include materials processing, original equipment manufacturer (OEM) components and instrumentation and microelectronics. SLS develops and manufactures configurable, advanced performance products serving the microelectronics, scientific research and government programs and OEM components and instrumentation markets. The Company’s products address a range of applications the Company group into the four markets: Microelectronics, Materials Processing, OEM Components and Instrumentation, and Scientific Research and Government Programs.

 

Confident Investor comments: At this price and at this time, I do not think that a Confident Investor can confidently invest in Coherent, Inc.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Coherent, Inc. calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $55.74
  • Growth: 0.08
  • Current EPS (TTM): $2.42
  • P/E: 23
  • Future EPS Calc: $3.55
  • Future Stock Price Calc: $81.78
  • Target stock price: $50.78

I hope that this makes you a better investor. [/s2If]

By:
On:
In: Fair company, Stock analysis
Tagged:
With: 0 Comments

Company name CME Group Inc
Stock ticker CME
Live stock price [stckqut]CME[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Good
Sales growth Poor
EPS growth Poor
P/E growth Good
EBIT growth Poor

ANALYSIS

Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $79.78
Target stock price (averages with growth) $76.71
Target stock price (averages with no growth) $42.63
Target stock price (manual assumptions) $80.08

The following company description is from Google Finance: http://www.google.com/finance?q=cme

CME Group Inc. (CME Group) offer a range of global products across all asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate. The Company’s products include both exchange-traded and over-the-counter derivatives. CME Group also provides clearing and settlement services for exchange-traded contracts, as well as for cleared over-the-counter derivatives transactions. In April 2012, it acquired a 100% interest in GreenX Holdings LLC. On July 2, 2012, S&P Capital IQ, a business line of The McGraw-Hill Companies acquired London-based Credit Market Analysis Limited (CMA) from CME Group. In November 2013, CME Group Inc announced the sale of the NYMEX Building located at One North End Avenue to Brookfield Office Properties.

 

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in CME Group Inc as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of CME Group Inc calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $81.61
  • Growth: 0.1
  • Current EPS (TTM): $2.86
  • P/E: 28
  • Future EPS Calc: $4.6
  • Future Stock Price Calc: $128.96
  • Target stock price: $80.08

I hope that this makes you a better investor. [/s2If]